AIDSinfo Releases Fact Sheets on Two New HIV Medications

At-a-Glance
Issue No. 20 | September 6, 2018

News and Features

AIDSinfo Releases Fact Sheets on Two New HIV Medications The Food and Drug Administration (FDA) recently approved two antiretroviral medications to treat HIV infection in adults who have never taken HIV medicines before. Read the fact sheets below to learn about each medication: Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate) Pifeltro (doravirine) Delstrigo, a fixed-dose combination tablet, is a complete regimen for the treatment of HIV infection and should not be used with other HIV medicines. Pifeltro is always used in combination with other HIV medicines. Do you want to learn more about HIV medicines? Search the AIDSinfo Drug Database and view the FDA-Approved HIV Medicines fact sheet. September 18 is National HIV/AIDS and Aging Awareness Day According to the Centers for Disease Control and Prevention (CDC), in 2014, an estimated 45% of Americans living with diagnosed HIV were aged 50 and older. September 18 is National HIV/AIDS and Aging Awareness Day—a day to call attention to the challenges of HIV prevention, testing, treatment, and care that older Americans face. For example, although HIV risk factors are similar for all adults, older adults may be less aware of these factors and the importance of testing to detect HIV in its earliest stages. To learn more, visit the AIDSinfo National HIV/AIDS and Aging Awareness Day webpage [en español]. Recent HIV News from NIAID August 28, 2018: HIV/AIDS Research Yields Dividends Across Medical Fields August 30, 2018: Novel Intervention Halves Rate of Death Among People Living with HIV Who Inject Drugs